6
Participants
Start Date
June 30, 2011
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
Sapropterin
20 mg/kg, orally, daily, 1 year or patient chooses to discontinue therapy
The University of Texas Health Science Center at Houston, Houston
Collaborators (1)
BioMarin Pharmaceutical
INDUSTRY
The University of Texas Health Science Center, Houston
OTHER